ARCUTIS BIOTHERAPEUTIC
10.15
20-九月-24 14:59:59
15 分钟延时
股票
+0.01
+0.10%
今日范围
9.78 - 10.31
ISIN
N/A
来源
NASDAQ
-
29 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
22 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
14 1月 2024 03:00:00 条件 Nasdaq GlobeNewswire
-
14 1月 2024 03:00:00 条件 Nasdaq GlobeNewswire
-
15 12月 2023 16:11:43 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 12月 2023 21:00:49 条件 Nasdaq GlobeNewswire
-
29 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
03 11月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 11月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter 2023 Financial Results
25 10月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
20 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $100 Million Public Offering
19 10月 2023 22:45:47 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
19 10月 2023 15:04:44 条件 Nasdaq GlobeNewswire
-
06 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 10月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Appoints L. Todd Edwards as Chief Commercial Officer
27 9月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
25 9月 2023 08:00:47 条件 Nasdaq GlobeNewswire
-
19 9月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 9月 2023 15:00:00 条件 Nasdaq GlobeNewswire